Suppr超能文献

核受体的一般分子生物学和结构。

General molecular biology and architecture of nuclear receptors.

机构信息

University of Lille-Nord de France, F-59000 Lille, France.

出版信息

Curr Top Med Chem. 2012;12(6):486-504. doi: 10.2174/156802612799436641.

Abstract

Nuclear receptors (NRs) regulate and coordinate multiple processes by integrating internal and external signals, thereby maintaining homeostasis in front of nutritional, behavioral and environmental challenges. NRs exhibit strong similarities in their structure and mode of action: by selective transcriptional activation or repression of cognate target genes, which can either be controlled through a direct, DNA binding-dependent mechanism or through crosstalk with other transcriptional regulators, NRs modulate the expression of gene clusters thus achieving coordinated tissue responses. Additionally, non genomic effects of NR ligands appear mediated by ill-defined mechanisms at the plasma membrane. These effects mediate potential therapeutic effects as small lipophilic molecule targets, and many efforts have been put in elucidating their precise mechanism of action and pathophysiological roles. Currently, numerous nuclear receptor ligand analogs are used in therapy or are tested in clinical trials against various diseases such as hypertriglyceridemia, atherosclerosis, diabetes, allergies and cancer and others.

摘要

核受体(NRs)通过整合内外信号来调节和协调多种过程,从而在营养、行为和环境挑战面前维持体内平衡。NRs 在结构和作用方式上具有很强的相似性:通过对同源靶基因的选择性转录激活或抑制,这些基因可以通过直接的、依赖 DNA 结合的机制或通过与其他转录调节剂的串扰来控制,NRs 调节基因簇的表达,从而实现协调的组织反应。此外,NR 配体的非基因组效应似乎通过质膜上定义不明确的机制来介导。这些效应通过作为小分子亲脂性靶标的潜在治疗效果来介导,并且已经做出了许多努力来阐明其确切的作用机制和病理生理作用。目前,许多核受体配体类似物被用于治疗或正在临床试验中针对各种疾病进行测试,如高甘油三酯血症、动脉粥样硬化、糖尿病、过敏和癌症等。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d653/3637177/e1f7952aad9a/halms662279f1.jpg

相似文献

2
Nuclear receptor: Structure and function.核受体:结构与功能。
Prog Mol Biol Transl Sci. 2023;196:209-227. doi: 10.1016/bs.pmbts.2022.07.014. Epub 2022 Nov 21.
3
Structural studies on nuclear receptors.核受体的结构研究。
Cell Mol Life Sci. 2000 Nov;57(12):1748-69. doi: 10.1007/PL00000656.
8
Allosteric small molecule modulators of nuclear receptors.核受体的变构小分子调节剂。
Mol Cell Endocrinol. 2019 Apr 5;485:20-34. doi: 10.1016/j.mce.2019.01.022. Epub 2019 Jan 28.
9
Evolution of the repertoire of nuclear receptor binding sites in genomes.核受体结合位点在基因组中的进化。
Mol Cell Endocrinol. 2011 Mar 1;334(1-2):76-82. doi: 10.1016/j.mce.2010.10.021. Epub 2010 Nov 4.
10
Nuclear receptors in bone physiology and diseases.核受体在骨骼生理学和疾病中的作用。
Physiol Rev. 2013 Apr;93(2):481-523. doi: 10.1152/physrev.00008.2012.

引用本文的文献

1
Orphan nuclear receptor transcription factors as drug targets.孤儿核受体转录因子作为药物靶点。
Transcription. 2025 Apr-Jun;16(2-3):224-260. doi: 10.1080/21541264.2025.2521766. Epub 2025 Jul 11.
9
PROTAC Degrader of Estrogen Receptor α Targeting DNA-Binding Domain in Breast Cancer.靶向乳腺癌雌激素受体α DNA结合结构域的PROTAC降解剂
ACS Pharmacol Transl Sci. 2022 Oct 12;5(11):1109-1118. doi: 10.1021/acsptsci.2c00109. eCollection 2022 Nov 11.

本文引用的文献

1
Origins and activity of the Mediator complex.中介体复合物的起源和活性。
Semin Cell Dev Biol. 2011 Sep;22(7):729-34. doi: 10.1016/j.semcdb.2011.07.021. Epub 2011 Jul 28.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验